select a format

Single User License
USD 2500 INR 160425
Site License
USD 5000 INR 320850
Corporate User License
USD 7500 INR 481275

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Dyslexia Global Clinical Trials Review, H1, 2015

Dyslexia Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2573CTIDB
  • |
  • Pages: 61
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Dyslexia Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Dyslexia Global Clinical Trials Review, H1, 2015" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Dyslexia 5

Symptoms of dyslexia are: 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Dyslexia to Central Nervous System Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Subjects Recruited Over a Period of Time 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Prominent Drugs 23

Clinical Trial Profiles 24

Clinical Trial Overview of Top Companies 24

Eli Lilly and Company 24

Clinical Trial Overview of Eli Lilly and Company 24

Clinical Trial Overview of Top Institutes / Government 25

Eunice Kennedy Shriver National Institute of Child Health and Human Development 25

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 25

National Stroke Foundation 26

Clinical Trial Overview of National Stroke Foundation 26

University of Tasmania 27

Clinical Trial Overview of University of Tasmania 27

University of Munster 28

Clinical Trial Overview of University of Munster 28

Rehabilitation Hospital of The Pacific 29

Clinical Trial Overview of Rehabilitation Hospital of The Pacific 29

University of Oxford 30

Clinical Trial Overview of University of Oxford 30

Vanderbilt University 31

Clinical Trial Overview of Vanderbilt University 31

U.S. Department of Veterans Affairs 32

Clinical Trial Overview of U.S. Department of Veterans Affairs 32

Rabin Medical Center 33

Clinical Trial Overview of Rabin Medical Center 33

Five Key Clinical Profiles 34

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 61

List of Figures

Dyslexia Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Dyslexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Dyslexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10

Proportion of Dyslexia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 13

Dyslexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Dyslexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Dyslexia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Dyslexia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Dyslexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Dyslexia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21

Dyslexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

GlobalData Methodology 60

List of Tables

Dyslexia Therapeutics, Global, Clinical Trials by Region, 2015* 6

Dyslexia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Dyslexia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Proportion of Dyslexia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 13

Dyslexia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Dyslexia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Dyslexia Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Dyslexia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Dyslexia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Dyslexia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Dyslexia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21

Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22

Dyslexia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 24

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 25

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Stroke Foundation, 2015* 26

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2015* 27

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2015* 28

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehabilitation Hospital of The Pacific, 2015* 29

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 30

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 31

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 32

Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2015* 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Dyslexia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Dyslexia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com